Petros Pharmaceuticals, Inc. (PTPI): Total Assets

Annual figures by period end, from SEC filings.

$5.16M
As of 2025-12-31
$3.55M
As of 2026-06-30
-45.8%
3-year compound annual growth
-40.6%
5-year compound annual growth
$69.85M2020-12-31: $69.85M2021-12-31: $67.39M2022-12-31: $32.42M2023-12-31: $33.80M2024-12-31: $10.64M2025-12-31: $5.16M$5.16M
2020-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$5.16M-51.4%2026-04-15, Balance as of period end
2024-12-31$10.64M-68.5%2026-04-15, Balance as of period end
2023-12-31$33.80M+4.2%2025-03-31, Balance as of period end
2022-12-31$32.42M-51.9%2024-04-01, Balance as of period end
2021-12-31$67.39M-3.5%2023-03-31, Balance as of period end
2020-12-31$69.85Mn/a2022-03-31, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Petros Pharmaceuticals, Inc. (PTPI)2025-12-31$5.16M-51.4%
Polaryx Therapeutics, Inc. (PLYX)2025-12-31$5.17M+3.4%
Enveric Biosciences, Inc. (ENVB)2025-12-31$5.10M+65.3%
Azitra, Inc. (AZTR)2025-12-31$5.03M-31.7%
Quantum Cyber N.V. (QUCY)2025-12-31$5.33M-60.5%
60 Degrees Pharmaceuticals, Inc. (SXTP)2025-12-31$5.37M-6.8%
International Stem Cell Corp (ISCO)2025-12-31$4.82M-6.8%
AEON Biopharma, Inc. (AEON)2025-12-31$5.56M+77.0%
Jupiter Neurosciences, Inc. (JUNS)2025-12-31$5.56M-10.3%

Compare PTPI, PLYX, ENVB, AZTR side by side · Screen every company in Pharmaceutical Preparations ↗